Literature DB >> 27535046

DDB1 Stimulates Viral Transcription of Hepatitis B Virus via HBx-Independent Mechanisms.

Woohyun Kim1, Sooyoung Lee1, Yeongnam Son1, Chunkyu Ko1, Wang-Shick Ryu2.   

Abstract

HBx, a small regulatory protein of hepatitis B virus (HBV), augments viral DNA replication by stimulating viral transcription. Among numerous reported HBx-binding proteins, DDB1 has drawn attention, because DDB1 acts as a substrate receptor of the Cul4-DDB1 ubiquitin E3 ligase. Previous work reported that the DDB1-HBx interaction is indispensable for HBx-stimulated viral DNA replication, suggesting that the Cul4-DDB1 ubiquitin E3 ligase might target cellular restriction factors for ubiquitination and proteasomal degradation. To gain further insight into the DDB1-HBx interaction, we generated HBx mutants deficient for DDB1 binding (i.e., R96A, L98A, and G99A) and examined whether they support HBx-stimulated viral DNA replication. In contrast to data from previous reports, our results showed that the HBx mutants deficient for DDB1 binding supported viral DNA replication to nearly wild-type levels, revealing that the DDB1-HBx interaction is largely dispensable for HBx-stimulated viral DNA replication. Instead, we found that DDB1 directly stimulates viral transcription regardless of HBx expression. Through an HBV infection study, importantly, we demonstrated that DDB1 stimulates viral transcription from covalently closed circular DNA, a physiological template for viral transcription. Overall, we concluded that DDB1 stimulates viral transcription via a mechanism that does not involve an interaction with HBx. IMPORTANCE: DDB1 constitutes a cullin-based ubiquitin E3 ligase, where DDB1 serves as an adaptor linking the cullin scaffold to the substrate receptor. Previous findings that the DDB1-binding ability of HBx is essential for HBx-stimulated viral DNA replication led to the hypothesis that HBx could downregulate host restriction factors that limit HBV replication through the cullin ubiquitin E3 ligase that requires the DDB1-HBx interaction. Consistent with this hypothesis, recent work identified Smc5/6 as a host restriction factor that is regulated by the viral cullin ubiquitin E3 ligase. In contrast, here we found that the DDB1-HBx interaction is largely dispensable for HBx-stimulated viral DNA replication. Instead, our results clearly showed that DDB1, regardless of HBx expression, enhances viral transcription. Overall, besides its role in the viral cullin ubiquitin E3 ligase, DDB1 itself stimulates viral transcription via HBx-independent mechanisms.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27535046      PMCID: PMC5068517          DOI: 10.1128/JVI.00977-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replication.

Authors:  Amanda J Hodgson; Joseph M Hyser; Victor V Keasler; Yong Cang; Betty L Slagle
Journal:  Virology       Date:  2012-02-17       Impact factor: 3.616

2.  DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level.

Authors:  Chunkyu Ko; Sooyoung Lee; Marc P Windisch; Wang-Shick Ryu
Journal:  J Virol       Date:  2014-09-17       Impact factor: 5.103

3.  Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.

Authors:  Julie Lucifora; Silke Arzberger; David Durantel; Laura Belloni; Michel Strubin; Massimo Levrero; Fabien Zoulim; Olivier Hantz; Ulrike Protzer
Journal:  J Hepatol       Date:  2011-03-02       Impact factor: 25.083

4.  Hepatocyte-specific deletion of DDB1 induces liver regeneration and tumorigenesis.

Authors:  Sachie Yamaji; Mingjun Zhang; Jing Zhang; Yoko Endo; Elena Bibikova; Stephen P Goff; Yong Cang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-06       Impact factor: 11.205

5.  Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses.

Authors:  D Sitterlin; F Bergametti; P Tiollais; B C Tennant; C Transy
Journal:  Oncogene       Date:  2000-09-07       Impact factor: 9.867

6.  Hepatitis B virus X protein interferes with cell viability through interaction with the p127-kDa UV-damaged DNA-binding protein.

Authors:  N Lin-Marq; S Bontron; O Leupin; M Strubin
Journal:  Virology       Date:  2001-09-01       Impact factor: 3.616

7.  Hepatitis B virus X protein and simian virus 5 V protein exhibit similar UV-DDB1 binding properties to mediate distinct activities.

Authors:  Olivier Leupin; Séverine Bontron; Michel Strubin
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

8.  Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex.

Authors:  Françoise Bergametti; Delphine Sitterlin; Catherine Transy
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Hepatitis B virus X protein interacts with a probable cellular DNA repair protein.

Authors:  T H Lee; S J Elledge; J S Butel
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery.

Authors:  Ti Li; Eva I Robert; Pieter C van Breugel; Michel Strubin; Ning Zheng
Journal:  Nat Struct Mol Biol       Date:  2009-12-06       Impact factor: 15.369

View more
  8 in total

1.  Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.

Authors:  Alexander L Marchetti; Hu Zhang; Elena S Kim; Xiaoyang Yu; Sunbok Jang; Mu Wang; Haitao Guo
Journal:  J Virol       Date:  2021-10-27       Impact factor: 6.549

2.  Hepatitis B virus X protein counteracts high mobility group box 1 protein-mediated epigenetic silencing of covalently closed circular DNA.

Authors:  Elena S Kim; Jun Zhou; Hu Zhang; Alexander Marchetti; Maarten van de Klundert; Dawei Cai; Xiaoyang Yu; Bidisha Mitra; Yuanjie Liu; Mu Wang; Ulrike Protzer; Haitao Guo
Journal:  PLoS Pathog       Date:  2022-06-09       Impact factor: 7.464

3.  A Mass Spectrometry-Based Profiling of Interactomes of Viral DDB1- and Cullin Ubiquitin Ligase-Binding Proteins Reveals NF-κB Inhibitory Activity of the HIV-2-Encoded Vpx.

Authors:  Christine D Landsberg; Dominik A Megger; Dominik Hotter; Meike U Rückborn; Mareike Eilbrecht; Jassin Rashidi-Alavijeh; Sebastian Howe; Stefan Heinrichs; Daniel Sauter; Barbara Sitek; Vu Thuy Khanh Le-Trilling; Mirko Trilling
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

4.  STAT3-Dependent Gene TRIM5γ Interacts With HBx Through a Zinc Binding Site on the BBox Domain.

Authors:  Hongxiao Song; Fengchao Xu; Xiaoli Pang; Qingfei Xiao; Qi Wei; Bingxin Lei; Xiaolu Li; Xixi Fan; Guangyun Tan
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

Review 5.  Post-translational Modification Control of HBV Biological Processes.

Authors:  Fan Yang
Journal:  Front Microbiol       Date:  2018-11-01       Impact factor: 5.640

6.  Ddb1 Is Essential for the Expansion of CD4+ Helper T Cells by Regulating Cell Cycle Progression and Cell Death.

Authors:  Lingtao Yang; Wei Chen; Li Li; Yueyue Xiao; Shilin Fan; Quan Zhang; Tian Xia; Mengjie Li; Yazhen Hong; Tongjin Zhao; Qiyuan Li; Wen-Hsien Liu; Nengming Xiao
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561

Review 7.  Pathogenicity and virulence of Hepatitis B virus.

Authors:  Yu-Chen Chuang; Kuen-Nan Tsai; Jing-Hsiung James Ou
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

8.  HBx represses WDR77 to enhance HBV replication by DDB1-mediated WDR77 degradation in the liver.

Authors:  Hongfeng Yuan; Lina Zhao; Ying Yuan; Haolin Yun; Wei Zheng; Yu Geng; Guang Yang; Yufei Wang; Man Zhao; Xiaodong Zhang
Journal:  Theranostics       Date:  2021-07-25       Impact factor: 11.556

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.